AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimitoss M 4mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Minitoss Medicines

Salt Composition

Glimepiride (4mg) + Metformin (500mg)

Overview Glimitoss M 4mg/500mg Tablet SR

Diabexe Duo 4mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.

Primary Ingredients of Glimitoss M 4mg/500mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Glimitoss M 4mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimitoss M 4mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimitoss M 4mg/500mg Extended-Release Tablet with food.

Common Side effects of Glimitoss M 4mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimitoss M 4mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 4mg/500mg Glimitoss M SR tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medication with a meal.

How Glimitoss M 4mg/500mg Tablet SR works:

Glimepiride/Metformin 4mg/500mg extended-release tablets (Glimitoss M) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through a triple mechanism: decreased hepatic glucose production, reduced intestinal glucose uptake, and enhanced insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Glimitoss M 4mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimitoss M 4mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers before prescribing. Physician consultation is recommended.

Breast feedingBreast feedingUNSAFE

Extended-release Glimitoss M 4mg/500mg tablets are contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimitoss M 4mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimitoss M 4mg/500mg SR tablets. Physician consultation is essential. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimitoss M 4mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. In individuals with mild to moderate hepatic dysfunction, treatment typically commences with a reduced Glimitoss M 4mg/500mg SR tablet dosage; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimitoss M 4mg/500mg Tablet SR :

Should you forget to take a Glimitoss M 4mg/500mg SR Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimitoss M 4mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Glimitoss M 4mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it's inaccessible to children, pets, and others.
Glimitoss M 4mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimitoss M 4mg/500mg Tablet SR and seek immediate medical attention.
Glimitoss M 4mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glimitoss M 4mg/500mg SR Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimitoss M 4mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake is recommended at least annually, according to some researchers.
Glimitoss M 4mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimitoss M 4mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimitoss M 4mg/500mg Tab...
69
MRP 80
13% off